FDA: Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography

This guidance represents the Food and Drug Administration\'s (FDA\'s) current thinking on this topic. It is intended to help manufacturers of positron emission tomography (PET) drugs meet the requirements for the Agency’s current good manufacturing practice (CGMP) regulations for PET drugs.